MOV'D + Fitbit Monitoring for Sedentary Lifestyle
Trial Summary
What is the purpose of this trial?
This trial tests the MOV'D program, which sends short exercise videos and tips via social media to help people take breaks from sitting at work. It targets those who sit a lot and don't get enough exercise, aiming to improve heart health by encouraging regular exercise breaks.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Fitbit Self-Monitoring, MOV'D (Move Often eVery Day) for sedentary lifestyle?
Is the MOV'D + Fitbit Monitoring treatment safe for humans?
How is the MOV'D treatment with Fitbit monitoring different from other treatments for a sedentary lifestyle?
Research Team
Marily A. Oppezzo, PhD MS, RDN, DipACLM
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for full-time employees who spend over half their work time sitting, can safely exercise (as determined by the PAR-Q), read English, and have a smartphone with internet. It's not suitable for those who don't meet these criteria.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomly assigned to either the MOV'D intervention or a Fitbit-only control for one month
Follow-up
Participants are monitored for changes in MVPA minutes and active workday hours
Treatment Details
Interventions
- Fitbit Self-Monitoring
- MOV'D (Move Often eVery Day)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator
National Institutes of Health (NIH)
Collaborator